Company Profile

Daiichi Sankyo (OTC: DSNKY)
4:50 PM UTC, 07/03/24
Last: $35.23 Change: +0.34 %Change: +0.97% Volume: 32,872
Detailed Quote
Open: $ 33.93   Volume: 32,872
High: $ 35.23   Yield(%) 0.80
Low: $ 33.93   P/E Ratio (ttm): 48.30
Dividend ($): 0.09   Market Cap ($): 67.05B
EPS ($) 0.73   Shares Out: 1.92B
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -0.31
% Price Change (last 13 weeks): 14.41
% Price Change (last 26 weeks): 28.20
% Price Change (last 52 weeks): 10.36
% Price Change (year to date): 27.33
Management Effectiveness
Return on Equity (%): 12.61
Return on Assets (%): 6.65
Return on Invested Capital (%): 7.32
Profitability
Gross Profit Margin (%): 73.78
Net Profit Margin (%): 12.53
Operating Profit Margin (%): 11.61
Price & Volume
50-day Moving Average: $34.43
200-day Moving Average: $30.46
Avg. Daily Vol. (last 50 days): 166,755
Avg. Daily Vol. (last 200 days): 134,818
52-wk high: $37.72
52-wk low: $23.72
Bid: $n/a
Ask: $n/a
Company Information
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.
Daiichi Sankyo
Daiichi Sankyo Head Office Bldg, A&B 3-5-1 Nihonbashi-honcho Chuo-Ku
Tokyo TY 103-8426

Phone: 81.3.6225.1111
Fax: n/a
http://www.daiichisankyo.co.jp
Per Share Data
Earnings (1year) ($): 0.73
Annual Dividend ($): 0.28
Current P/E Ratio (ttm): 48.30
Book Value ($): 5.82
Cash Flow ($): 0.96
Valuation Ratios
Price/Earnings (x): 48.30
Price/Sales (x): 5.49
Price/Book (x): 5.45
Price/Cash Flow (x): 14.68
Financial Strength
Quick Ratio (x): 2.40
Current Ratio (x): 3.01
LT Debt/Equity (x): 8.48
Total Debt/Equity (x): 9.24



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.